• 0Shopping Cart
Aspire Medical Innovation
  • News
    • Blog
    • Newsletter
    • Events & Tradeshows
  • Products
    • Bone Marrow Aspiration
    • Bone Dowel Harvesting
    • Sub-Chondral Access
    • Platelet Plasma/PRP
    • Adipose Fat Grafting
    • Delivery Systems
    • Hematology
    • Other
      • Ergonomics
  • MARROW CELLUTION™
    • MARROW CELLUTION™
    • Product Details
    • Media & Presentations
    • Documentation
    • References
    • FAQ
  • About
    • About us
    • What we do
    • Our Partners
  • Contact
  • Search
  • Menu Menu
You are here: Home1 / News2 / Marrow Cellution3 / MC Publication/Study4 / Phase I and registry study of autologous bone marrow concentrate evaluated...

Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction

14/01/2020/in Marrow Cellution, MC Publication/Study

Mark Bieri, Elias Said, Gabrielle Antonini, Donald Dickerson, Jorge Tuma, Courtney E. Bartlett, Amit N. Patel & Alexander Gershman

J Transl Med 18, 24 (2020) | doi: 10.1186/s12967-019-02195-w

Background: Bone marrow mononuclear cells have been successfully utilized for numerous regenerative purposes. In the current study, patients suffering from erectile dysfunction (ED) unresponsive to phosphodiesterase 5 inhibitors were administered autologous bone marrow concentrate delivered intracavernously utilizing a point of care FDA cleared medical device.

Methods: Bone marrow mononuclear cells have been successfully utilized for numerous regenerative purposes. In the current study, patients suffering from erectile dysfunction (ED) unresponsive to phosphodiesterase 5 inhibitors were administered autologous bone marrow concentrate delivered intracavernously utilizing a point of care FDA cleared medical device.

Results: Minimal treatment associated adverse effects where observed related to short term bruising at the site of harvest or injection. No long-term adverse events were noted related to the intervention. Mean improvements in IIEF-5 score were 2 in the Caverstem 1.0 low dose group, 3 in the high dose Caverstem 1.0 group and 9 in the Caverstem 2.0 group. Furthermore, improvements peaked by 3 months and maintained at 6 months follow-up.

Conclusions: These data support the safety and efficacy of point of care, minimally to non-manipulated, non-expanded bone marrow concentrate for the treatment of ED.

View Study

____________________________________________________________

The Marrow Cellution™ System is designed to minimize and eliminate the restrictive limitations associated with “point of care” processing systems which employ inefficient traditional aspiration trocar technology and are regulated as drugs “Advanced Therapies Medicinal Products (ATMP)”.  Marrow Cellution™ is a minimally invasive bone/cell enriched autograft access and retrieval system, which does not require additional manipulation or processing, it never leaves the sterile field and provides rich autograft without associated morbidity.

Visit our Marrow Cellution product page

Share this entry:

  • tweet 
  • share 
  • share 
  • share 
  • share 
  • share 
  • email 
  • print 
https://aspire-medical.eu/wp-content/uploads/2020/01/Bieri_JTranslMed_2020.jpg 348 918 admin https://aspire-medical.eu/wp-content/uploads/2017/12/ASPIRE-Logo_510x154px_XMAS-300x91.png admin2020-01-14 20:48:152023-01-23 16:55:58Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction
You might also like
A review of bone marrow lesions in the arthritic knee and description of a technique for treatment
Sub-Chondral Bone Augmentation
Marrow Cellution BrochureNew Marrow Cellution™ brochure available
Matrix Biosurgical Inc.Marrow Cellution™ vs. BMA Concentrate Systems
Osteo-Core-Plasty™ with Marrow Cellution™
MARROW CELLUTION™ vs. Harvest BMAC®

Categories

Recent
  • Experts Achieve Consensus on a Majority of Statements Regarding...27/11/2023 - 16:05
  • ICRS Patient Registry01/06/2023 - 15:39
  • CERVOS Medical Bone Marrow Aspirate Didactic Webinar04/05/2023 - 12:47
  • Chronic Lower Back Pain in a Snowboard Cross World Cham...27/03/2023 - 19:04
Popular
  • Novel Technology to Increase Concentrations of Stem and...13/06/2016 - 15:43
  • Experts Achieve Consensus on a Majority of Statements Regarding...27/11/2023 - 16:05
  • New Address & Contact Details02/02/2016 - 20:32
  • MARROW CELLUTION™ vs. Harvest BMAC®25/10/2016 - 16:56

Landing pages

Marrow Cellution™

CERVOS KeyPRP

Product Categories

Bone Marrow Aspiration

Bone Dowel Harvesting

Sub-Chondral Access

Platelet Plasma/PRP

Adipose Fat Grafting

Delivery Systems

Hematology

Other

Med. Specialities

Extremity

Intradiscal

Neuro Spine

Ortho Spine

Ortho / SportsMed

Pain Management

Plastic Surgery

Trauma

Company

About us

Providing Market Access

Our Partners

Events & Tradeshows

Newsletter

Blog

Contact

Resources

Online-Tools

PRP Library

Certificates

Intranet →

ASPIRE Medical Innovation  |  Einsteinstraße 167  |  81677 Munich  |  Germany

© Aspire Medical Innovation 2015-2023 │We ♥ our clients
  • Twitter
  • LinkedIn
  • Youtube
  • Mail
  • Home
  • Terms
  • Privacy/Datenschutz
  • Disclaimer
Technique Matters: Small Draw, Diverse Geography, Precise Repositioning, Lateral...Comparison of Two Methods to Harvest Vertebral Body Marrow Aspirate: Novel Lateral...
Scroll to top

This website uses cookies. These are small text files that are stored on your end device with the help of the browser. They do not cause any damage. Cookies are used to make our website user-friendly. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Policy

ACCEPT ALLACCEPT ESSENTIAL ONLYPrivacy & Cookie Settings

Cookie and Privacy Settings



How we use cookies

Our website uses so-called cookies. These are small text files that are stored on your end device with the help of the browser. They do not cause any damage.

We use cookies to make our website user-friendly and to enrich your user experience. Some cookies may remain stored on your end device until you delete them. They enable us to recognise your browser on your next visit.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may limit your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.

Analytical Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit on our site you can disable tracking in your browser here:

Functional Cookies

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfonts Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

Product catalogue Settings:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy-Policy
Accept allAccept settingsHide notification only
Open Message Bar